CARDON BIO
0782.633.810 · rovalta.com · 22/09/2026
CARDON BIO
Overview
What does CARDON BIO do?
CARDON BIO is a Public limited company incorporated in 2022. Its main activity is: Retail sale of medical and orthopaedic goods in specialised stores. Its registered office is in Gent.
9052 Gent · FlandreSee on map
Trend over 4 financial years
| 2025 | 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Gross margin | 25,6 k € | -63.6% | 70,4 k € | +2558% | 2,6 k € | +130% | -8,8 k € |
| EBITDA | 25,2 k € | +24.5% | 20,2 k € | +664% | 2,6 k € | +129% | -9,2 k € |
| Operating result | 25,2 k € | +24.5% | 20,2 k € | +664% | 2,6 k € | +125% | -10,5 k € |
| Net result | 17,5 k € | +4.1% | 16,8 k € | +558% | 2,6 k € | +124% | -10,5 k € |
| Balance sheet | |||||||
| Equity | 88,4 k € | +24.7% | 70,9 k € | +31.1% | 54,1 k € | +5.0% | 51,5 k € |
| Total assets | 324,6 k € | +173% | 118,9 k € | +56.0% | 76,2 k € | +4.5% | 72,9 k € |
| Cash | 122,3 € | -69.0% | 394,2 € | +183% | 139,3 € | -99.4% | 22,6 k € |
| Debts | 236,2 k € | +392% | 48 k € | +117% | 22,1 k € | +3.3% | 21,4 k € |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 2 active · 7 ended
Active mandates
Other companies at this address
| Company | CBE no. |
|---|---|
BELLEVUE● Active | 0841.241.408 |
BORDEAUX I● Active | 0839.861.632 |
CELL-CELL BIO● Active | 0782.638.362 |
DOING WELL BY DOING GOOD● Active | 0476.250.994 |
RNA Pioneering● Active | 0456.792.695 |
Ziphius● Active | 0750.500.975 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 25/02/2022 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
| Length of the financial year | 12 months | 12 months | 12 months | 11 months |
| Filing date | 28/08/2026 | 29/08/2025 | 29/08/2024 | 31/08/2023 |
| General meeting | 13/08/2026 | 26/08/2025 | 28/08/2024 | 29/08/2023 |
| Currency of the financial year | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
5 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 13/08/2026 | 28/08/2026 | Dutch | |
| Abridged model | 31/12/2024 | 26/08/2025 | 29/08/2025 | Dutch | |
| Abridged model | 31/12/2023 | 28/08/2024 | 29/08/2024 | Dutch | |
| Abridged modelCorrection | 31/12/2022 | 29/08/2023 | 31/08/2023 | Dutch | |
| Abridged model | 31/12/2022 | 30/06/2023 | 27/07/2023 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 2 active · 7 ended
Active mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202517,5 k €↑
- 2024Annual accounts 202416,8 k €↑
- 2023Annual accounts 20232,6 k €↑
- 2023Name changeCARDON BIO
- 2022Annual accounts 2022-10,5 k €
- 25/02/2022IncorporationPublic limited company
- 2022Name changeSaiga Pharma